Said Darwazah, the Chief Executive Officer of Hikma Pharmaceuticals, the FTSE 250 multinational pharmaceutical group, has pocketed over one million pounds through the sale of company shares last week.
Darwazah sold 195,447 shares at 649p each on June 15th for a total of £1,268,451, the company revealed in a statement on Thursday. This was equal to 0.99% of the issued share capital of Hikma.
Following the transaction, he still owns over two million shares in the firm, equal to a 1.08% stake.
Darwazah is the former Minister of Health in Jordan from 2003 to 2006 and also held a position on the board of the Central Bank of Jordan.
Last month, the company reiterated its revenue growth guidance for 2012. "We are making good progress towards delivering our targets for this year and surpassing the important milestone of $1bn in revenue," Darwazah said at the time.
The group announced 28% growth in its branded business during the first four months of the year, along with 12% organic revenue growth.
Hammerson, the property development and investment company, has raised funds to repay existing debt and refinance upcoming bond maturities through the placement of seven-, 10- and 12-year notes. [29 Nov '13]
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.